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ABSTRACT. The reaction of 2-amino-3-cyano-tetrahydrobenzothiophene 3 with ethyl acetoacetate gave the 
amide derivatives 5. The reactivity of 5 toward a variety of chemical reagents was studied to give pyrans, 
pyridines, thiophenes and the thiazoles and their fused derivatives. The structures of the newly synthesized 
products were confirmed on the basis of their respective analytical and spectral data. The antitumor evaluations of 
the synthesized compounds against the three cancer cell lines MCF-7, NCI-H460 and SF-268 showed that 
compounds 9a, 9c, 12a and 14 were of the highest potencies against the three cancer cell lines among the tested 
compounds. 
  




Aromatic thiophenes play on part in animal metabolism; for examples, Biotin, one of the 
vitamins (Vitamin H) (Figure 1), is a tetrahydrothiophene, however aromatic thiophenes do 
occur in some plants, in association with polyacetylenes with which they are biogenetically 
linked and Banminth (pyrantel), available anthelmintic used in animal husbandry, is one of the 
thiophene compounds in chemotherapy. Thiophenes with a wide spectrum of biological 
activities are known, several of these derivatives possess potent analgesic [1, 2],  anticonvulsant, 
anti-inflammatory and antibacterial [3-6],  antipyretics [7],  antitumor [8, 9],  antiparasitic [10], 
antimicrobial [11],  antihistaminic (H1) [12],  antianexiety test in mice [13],  antiarrhythmic [14]  
and serotonin antagonist [15]. In previous work we have found that certain substituted 
thiophenes and their heterocyclic derivatives show antitumor activities [16-18]. In the present 
work we were aiming the synthesis of new heterocyclic derivatives derived from the 2-amino-3-




Figure 1. Chemical structures of (+)-Biotin and Banminth. 
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RESULTS AND DISCUSSION 
Chemistry 
In the present work we synthesised a series of heterocyclic rings incorporated 
tetrahydrobenzo[b]thiophene moiety through the use of 2-amino-3-cyano-4,5,6,7-tetrahydro- 
benzo[b]thiophene (3). Compound 3 was synthesized via the reaction of cyclohexanone (1) with 
malononitrile (2) and elemental sulfur [19, 20]. Compound 3 reacted with ethyl acetoacetate (4) 
in dimethylformamide under reflux to give the amide derivative (5). The multi-component 
reaction of compound 5 and any of the aromatic aldehydes namely benzaldehyde (6a), 4-
chlorobenzaldehyde (6b) or 4-methoxybenzaldehyde (6c) in 1,4-dioxane  containing triethyl- 
amine with malononitrile gave the pyran derivatives 7a-c, respectively (Scheme 1). The 
analytical and spectral data of compounds 7a-c were the basis of their structural elucidation. 
Thus, the 1H NMR spectrum of 7a (as an example) revealed beside the expected signals a singlet 
at  3.19 ppm corresponding to the CH3 group, a singlet at  6.01 ppm corresponding to the 
pyran H-4 a multiplet at  7.28-7.39 ppm equivalent to the C6H5 group and a singlet at  8.63 
ppm, D2O exchangeable, for the NH group.   
 
Scheme 1. Synthesis of compounds 5, 6a-c and 7a-c. 
Synthesis and cytotoxicity of novel thiophene, pyran and pyridine derivatives 
Bull. Chem. Soc. Ethiop. 2018, 32(2) 
261
 
Scheme 2. Synthesis of compounds 8a-c and 9a-c. 
 
In addition the 13C NMR spectrum showed, beside the expected signals, 22.8 (CH3), 88.3 
(pyran C-4), 116.2, 118.3 (2CN), 120.3, 121.3, 121.8, 122.4, 126.0, 128.4, 124.2, 130.8, 133.0, 
134.2, 137.3, 139.2 (benzene, pyran, thiophene C), 165.8 (CO). Moreover, the multi-component 
reaction of compound 5 with any of the aromatic aldehydes namely benzaldehyde (6a), 4-
chlorobenzaldehyde (6b) or 4-methoxybenzaldehyde (6c) in 1,4-dioxane  containing ammonium 
acetate gave the pyridine derivatives 8a-c. Compounds 7a-c each with the acetyl group at the 
pyran ring found to be capable for the Gewald’s thiophene synthesis. Thus, any of compounds 
7a-c reacted with malononitrile and elemental sulfur to give the thiophene derivatives 9a-c, 
respectively. The analytical and spectral data of 9a-c were consistent with their respective 
structures as depicted in Scheme 2. Thus, the 1H NMR spectrum of 9a revealed, beside the 
expected signals, the presence of two singlets at  4.38, 4.70 ppm (D2O exchangeable) 
equivalent to the two NH2 groups, a singlet at  5.96 ppm corresponding to the thiophene H-5, a 
singlet at  6.04 ppm for the pyran H-4 and a singlet at  8.39 ppm (D2O exchangeable) 
equivalent for the NH group. The 13C NMR spectrum showed  88.6 (pyran C-4), 115.7, 116.0, 
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116.3 (3CN), 119.5, 120.8, 121.3, 122.9, 123.3, 126.9, 127.5, 130.8, 132.6, 133.5, 137.7, 138.5, 
139.7, 140.6, 142.9, 145.2 (benzene, pyran, two thiophene C).  
Similarly, the pyridine derivatives 8a-c reacted with malononitrile and elemental sulfur to 
give the thiophene derivatives 10a-c, respectively. The reaction of compound 5 with either of 
malononitrile (2) or ethyl cyanoacetate (11) and elemental sulfur in 1,4-dioxane containing a 
catalytic amount of triethylamine gave the thiophene derivatives 12a and 12b, respectively.  
Analytical and spectral data were the basis of their respective structure elucidation. Finally, the 





Scheme 3. Synthesis of compounds 10a-c, 12a,b and 14. 
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Antitumor and normal cell line activity tests 
 
Chemicals. Fetal bovine serum (FBS) and L-glutamine were from Gibco Invitrogen Co. 
(Scotland, UK). RPMI-1640 medium was from Cambrex (New Jersey, USA). Dimethyl 
sulfoxide (DMSO), doxorubicin, penicillin, streptomycin and sulforhodamine B (SRB) were 
from Sigma Chemical Co. (Saint Louis, USA).  
 
Cell cultures. Three human tumor cell lines, MCF-7 (breast adenocarcinoma), NCI-H460 (non-
small cell lung cancer), and SF-268 (CNS cancer) were used. MCF-7 was obtained from the 
European Collection of Cell Cultures (ECACC, Salisbury, UK), NCI-H460, SF-268 and normal 
fibroblast cells (WI 38) were kindly provided by the National Cancer Institute (NCI, Cairo, 
Egypt). They grow as monolayer and routinely maintained in RPMI-1640 medium 
supplemented with 5% heat inactivated FBS, 2 M glutamine and antibiotics (penicillin 100 
U/mL, streptomycin 100 µg/mL), at 37 oC in a humidified atmosphere containing 5% CO2. 
Exponentially growing cells were obtained by plating 1.5 x 105 cells/mL for MCF-7 and SF-268 
and 0.75 x 104 cells/mL for NCI-H460, followed by 24 h of incubation. The effect of the 
vehicle solvent (DMSO) on the growth of these cell lines was evaluated in all the experiments 
by exposing untreated control cells to the maximum concentration (0.5%) of DMSO used in 
each  assay. 
 
Tumor cell growth assay. The effects of the newly synthesized products on the in vitro growth 
of human tumor cell lines were evaluated according to the procedure adopted by the National 
Cancer Institute (NCI, USA) in the ‘In vitro Anticancer Drug Discovery Screen’ that uses the 
protein-binding dye sulforhodamine B to assess cell growth. Briefly, exponentially, cells 
growing in 96-well plates were then exposed for 48 h to five serial concentrations of each 
compound, starting from a maximum concentration of 150 µM. Following this exposure period 
adherent cells were fixed, washed, and stained. The bound stain was solubilized and the 
absorbance was measured at 492 nm in a plate reader (Bio-Tek Instruments Inc., Power wave 
XS, Wincoski, USA). For each test compound and cell line, a dose–response curve was obtained 
and the growth inhibition of 50% (GI50), corresponding to the concentration of the compounds 
that inhibited 50% of the net cell growth was calculated as described elsewhere. Doxorubicin 
was used as a positive control and tested in the same manner. 
Results are given in concentrations that were able to cause 50% of cell growth inhibition 
(GI50) after a continuous exposure of 48 h and show means ± SEM of three-independent 
experiments performed in duplicate.  
 
Structure activity relationship 
 
It is clear from Table 1 that the 2-amino-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carbonitrile (3)  
showed high cytotoxicity against MCF-7 with GI50 0.30 mol L
-1 but it showed low cytotoxicity 
against  NCI-H460. The reaction of compound 3 with ethyl acetoacetate gave the amide 
derivative 5 which showed moderate cytotoxicity against NCI-H460 and SF-268 with GI50's 3.1 
and 1.96 mol L-1. For the multi-component products 7a-c it is obvious that compound 7c (X = 
OCH3) showed the highest cytotoxicity among the three compounds. On the other hand, the 
pyridine derivatives 8a-c were of low potency towards the three cancer lines. The reaction of 
any of compounds 7a-c with elemental sulfur and malononitrile to yield the thiophene 
derivatives 9a-c where compounds 9a (X = H) and 9c (X = OCH3) showed the highest 
cytotoxicity among the three compounds. On the other hand, compounds 10a-c showed low 
potencies. Considering the dithiophene derivatives 12a,b, it is clear that compound 12a with X 
= CN showed the higher potency than 12b, X = COOEt. It is clear that the presence of the CN 
group is responsible for its reactivity. Finally, the thiazole derivative 14 showed high potency 
against the three cancer cell lines. 
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Table 1. Effect of newly synthesized compounds on the growth of three human tumor cell lines. 





All melting points were determined on an Electrothermal digital melting point apparatus and are 
uncorrected. IR spectra (KBr discs) were recorded on a FTIR plus 460 or Pyeunicam SP-1000 
spectrophotometer. 1H NMR spectra were recorded with Mercury-300BB (300 MHz) (Cairo 
University) instrument in DMSO-d6 as solvent using TMS as internal standard and chemical 
shifts are expressed as  ppm. 13C-NMR spectra were recorded in DMSO. Analytical data were 
obtained from the micro analytical data unit at Cairo University and were performed on Vario El 




Ethyl acetoacetate (13.0 g, 0.1 mol) was heated till 140 oC then compound 3 (17.8 g, 0.1 mol) 
was added with continuous heating till the temperature reach 125 oC at this moment the whole 
reaction mixture is heated under reflux for 20 min. The reaction mixture was allowed to cool 
overnight and the formed solid product was filtered, dried and crystallized from ethanol to give 
compound 5.  
 
General procedure for the synthesis of the pyran derivatives 7a-c 
 
To a solution of compound 5 (2.62 g, 0.01 mol) in 1,4-dioxane (40 mL) containing triethyl 
amine (0.50 mL) any of  benzaldehyde (1.06 g, 0.01 mol), 4-chlorobenzaldehyde  (1.41 g, 0.01 
mol) or 4-methoxybenzaldehyde (1.36 g, 0.01 mol) and malononitrile (0.66 g, 0.01 mol) was 
added. The reaction mixture, in each case, was heated under reflux for 2 h then left to cool. The 
formed solid product was collected by filtration.  
 
Compound                                                  GI50 (mol L
-1) 
 MCF-7 NCI- H460 SF-268   WI 38    
3 0.30±0.02 1.80±0.09 4.20±1.04 >100 
5 22.3±0.2 3.1±0.22 1.96±0.09              >100 
7a 22.4±2.10 10.42±3.01 8.63±2.83 >100 
7b 23.55±4.06 34.6±12.06 45.41±2.16 >100 
7c 1.2±0.4 0.3±0.16 2.8±0.06  >100 
8a 26.6±8.5 29.3±12.3 18.4±2.8 68.2 ± 2.0 
8b 22.4±5.8  26.7±8.2 31.4±2.4  >100 
8c 20.8±8.30 22.8±4.32 22.8±6.23 >100 
9a 0.01±0.001 0.02±0.006   0.06±0.002 >100 
9b 24.1±10.4 30.8±10.8 26.1±2.8  25.2 ± 0.8 
9c 0.08±0.004 0.05±0.002 0.06±0.001 >100 
10a 36.6±10.2 33.0±8.6 38.6±8.0 >100 
10b 38.2±3.6 36.3±12.5       40.6±8.8  >100 
10c 30.0±1.4 20.8±4.3 20.3±2.8  >100 
12a 0.01±0.002 0.01±0.004 0.04±0.01                   - 
12b 60.06±8.33 58.03±12.3 33.1±10.82          - 
14 0.03±0.002 0.02±0.003 0.05±0.002          - 
Doxorubicin 0.04±0.008  0.09±0.008 0.09±0.007 >100                    
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2-(5-Acetyl-4-phenyl-4H-pyran-2-ylamino)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carbonitril 
(7a). Yield: 83%; m.p.: 125-128 oC; IR (KBr, cm-1) ν: 3477-3320 (NH2, NH), 3055 (CH 
aromatic), 2936-2850 (CH aliphatic), 2223, 2220 (2CN), 1689 (CO); 1H NMR (DMSO-d6) δ: 
1.73-2.46 (m, 8H, 4CH2), 3.19 (s, 3H, CH3), 4.49 (s, 2H, D2O exchangeable, NH2), 6.01  (s, 1H, 
pyran H-4), 7.28-7.39 (m, 5H, C6H5), 8.63 (s, 1H, NH, D2O exchangeable); 
13C NMR (DMSO-
d6, 400 MHz): 22.8 (CH3), 29.4, 30.5, 33.2, 38.6 (4CH2), 88.3 (pyran C-4), 116.2, 118.3 (2CN), 
120.3, 121.3, 121.8, 122.4, 126.0, 128.4, 124.2, 130.8, 133.0, 134.2, 137.3, 139.2 (benzene, 
pyran, thiophene C), 165.8 (CO); MS: m/z, (%): 416 (22). Anal. calcd. for C23H20N4O2S (416.5): 
C, 66.33; H,4.84; N,13.45; S,7.69. Found: C, 66.53; H, 4.92; N, 13.62; S, 7.92. 
 
2-(5-Acetyl-4-chlorophenyl-4H-pyran-2-ylamino)-4,5,6,7-tetrahydrobenzo[b]   thiophene-3-
carbonitril (7b). Yield: 78%; m.p. 85 oC; IR (KBr, cm-1) ν: 3473-3343 (NH2, NH), 3058 (CH 
aromatic), 2938-2873 (CH aliphatic), 2226, 2221 (2CN), 1687 (CO), 1630 (C=C); 1H NMR 
(DMSO-d6) δ: 1.70-2.48 (m, 8H, 4CH2), 3.17 (s, 3H, CH3), 4.48 (s, 2H, D2O exchangeable, 
NH2), 6.04  (s, 1H, pyran H-4), 7.23-7.42 (m, 4H, C6H4), 8.68 (s, 1H, NH, D2O exchangeable); 
13C NMR (DMSO-d6, 400 MHz): 22.8 (CH3), 29.4, 3 0.5, 33.2, 38.6 (4CH2), 88.3 (pyran C-4), 
116.1, 116.4 (2CN), 120.3, 121.3, 121.8, 122.4, 126.0, 128.4, 124.2, 130.8, 133.0, 134.2, 137.3, 
139.2 (benzene, pyran, thiophene C), 165.8 (CO); MS (m/z, %): 450 (36). Anal. calcd. for 
C23H19ClN4O2S (450.94): C, 61.26; H, 4.25; N, 12.42; S, 7.11. Found: C, 61.09; H, 4.31; N, 
12.69; S, 7.08.  
 
2-(5-Acetyl-4-methoxyphenyl-4H-pyran-2-ylamino)-4,5,6,7-tetrahydrobenzo[b] thiophene-3-
carbonitril (7c). Yield: 68%; m.p. 145-148  oC; IR (KBr, cm-1) ν: 3495-3318 (NH2, NH), 3056 
(CH aromatic), 2972-2893 (CH aliphatic), 2224, 2220 (2CN), 1689 (CO), 1630 (C=C); 1H NMR 
(DMSO-d6) δ: 1.72-2.40 (m, 8H, 4CH2), 3.11, 3.24 (2s, 6H, 2CH3), 4.44 (s, 2H, D2O 
exchangeable, NH2), 6.02 (s, 1H, pyran H-4), 7.28-7.36 (m, 4H, C6H4), 8.60 (s, 1H, NH, D2O 
exchangeable); 13C NMR (DMSO-d6, 400 MHz): 22.6 (CH3), 29.2, 30.5, 33.7, 38.4 (4CH2), 
32.12 (CH3), 88.6 (pyran C-4), 115.8, 116.2 (2CN), 120.6, 122.0, 122+.2, 122.4, 125.3, 127.0, 
128.3, 130.3, 133.3, 135.0, 136.2, 139.0 (benzene, pyran, thiophene C), 165.9 (CO); MS (m/z, 
%): 446 (22). Anal. calcd. for C24H22N4O3S (446.52): C, 64.56; H, 4.97; N, 12.55; S, 7.18. 
Found: C, 64.25; H, 4.77; N, 12.73; S, 7.16. 
 
General procedure for the synthesis of the pyridine derivatives 8a-c 
 
To a solution of compound 5 (2.62 g, 0.01 mol) in 1,4-dioxane (40 mL) containing ammonium 
acetate (0.50 mL) any of  benzaldehyde (1.06 g, 0.01 mol), 4-chlorobenzaldehyde  (1.41 g, 0.01 
mol) or 4-methoxybenzaldehyde (1.36 g, 0.01 mol) malononitrile (0.66 g, 0.01 mol) was added. 
The reaction mixture, in each case, was heated under reflux for 4 h then left to cool. The formed 
solid product was collected by filtration.  
 
2-(5-Acetyl-1,4-dihydro-4-phenylpyridin-2-ylamino)-4,5,6,7-tetrahydrobenzo [b]thiophene-3-
carbonitril (8a). Yield: 77%; m.p. 102-104  oC; IR (KBr, cm-1) ν: 3483-3316 (NH2, 2NH), 3053 
(CH aromatic), 2948-2862 (CH aliphatic), 2224, 2220 (2CN), 1687 (CO), 1633 (C=C); 1H NMR 
(DMSO-d6) δ: 1.70-2.43 (m, 8H, 4CH2), 3.16 (s, 3H, CH3), 4.44 (s, 2H, D2O exchangeable, 
NH2), 6.01 (s, 1H, pyran H-4), 7.25-7.39 (m, 5H, C6H5), 8.60, 8.72 (2s, 2H, 2NH, D2O 
exchangeable); 13C NMR (DMSO-d6, 400 MHz): 22.7 (CH3), 29.0, 30.8, 32.9, 38.9 (4CH2), 88.2 
(pyran C-4), 116.2, 116.9 (2CN), 120.6, 121.0, 121.6, 122.0, 124.7, 127.9, 128.3, 130.5, 133.2, 
133.9, 137.7, 139.3 (benzene, pyridine, thiophene C), 166.0 (CO); MS (m/z, %): 415 (18). Anal. 
calcd. for C23H21N5OS (415.51): C, 66.48; H, 5.09; N, 16.85; S, 7.72. Found: C, 66.50; H, 4.92; 
N, 16.53; S, 7.92. 
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 2-(5-Acetyl-1,4-dihydro-4-chloro-phenylpyridin-2-ylamino)-4,5,6,7-tetrahydrobenzo[b]thioph- 
ene-3-carbonitril (8b). Yield 79%; m.p.: 116-119  oC; IR (KBr, cm-1) ν: 3488-3323 (NH2, 2NH), 
3058 (CH aromatic), 2938-2873 (CH aliphatic), 2226, 2221 (2CN), 1687 (CO), 1630 (C=C); 1H 
NMR (DMSO-d6) δ: 1.73-2.45 (m, 8H, 4CH2), 3.14 (s, 3H, CH3), 4.45 (s, 2H, D2O 
exchangeable, NH2), 6.02  (s, 1H, pyran H-4), 7.26-7.45 (m, 4H, C6H4), 8.33, 8.65 (2s, 2H, 
2NH, D2O exchangeable); 
13C NMR (DMSO-d6, 400 MHz): 22.4 (CH3), 28.3, 31.8, 32.8, 37.1 
(4CH2), 88.6 (pyran C-4), 116.0, 116.3 (2CN), 120.3, 121.6, 121.8, 122.2, 124.8, 127.0, 128.3, 
131.9, 132.8, 134.9, 138.5, 139.2 (benzene, pyran, thiophene C), 164.8 (CO); MS (m/z, %): 449 
(38). Anal. calcd. for C23H20ClN5OS (449.11): C, 61.39; H, 4.48; N, 15.56; S, 7.13. Found: C, 
61.42; H, 4.63; N, 15.36; S, 7.28.  
 
2-(5-Acetyl-1,4-dihydro-4-methoxy-phenylpyridin-2-ylamino)-4,5,6,7-tetrahydrobenzo[b]thio- 
phene-3-carbonitril (8c). Yield:  83%; m.p.: 140-142 oC; IR (KBr, cm-1) ν: 3495-3318 (NH2, 
2NH), 3056 (CH aromatic), 2972-2893 (CH aliphatic), 2224, 2220 (2CN), 1689 (CO), 1630 
(C=C); 1H NMR (DMSO-d6) δ: 1.72-2.40 (m, 8H, 4CH2), 3.11, 3.24 (2s, 6H, 2CH3), 4.44 (s, 
2H, D2O exchangeable, NH2), 6.02 (s, 1H, pyran H-4), 7.28-7.36 (m, 4H, C6H4), 8.32, 8.60 (2s, 
2H, 2NH, D2O exchangeable); 
13C NMR (DMSO-d6, 400 MHz): 22.6 (CH3), 29.2, 30.5, 33.7, 
38.4 (4CH2), 32.12 (CH3), 88.6 (pyran C-4), 115.8, 116.4 (2CN), 120.2, 122.3, 122.8, 122.4, 
125.3, 127.8, 129.1, 132.7, 133.6, 135.0, 136.2 (benzene, pyran, thiophene C), 165.6 (CO); MS 
(m/z, %):  445 (16).  Anal. calcd. for C24H23N5O2S  (445.54): C, 64.70; H, 5.20; N, 15.72; S, 
7.20. Found: C, 64.49; H, 5.26; N, 15.91; S, 7.42. 
 
General procedure for the synthesis of the 5-amino-4-cyanothiophen-3-yl)-4-phenyl-4H-pyran 
derivatives 9a-c 
 
To a solution of any of compound 7a (4.15 g, 0.01 mol), 7b (4.50 g, 0.01 mol) or 7c (4.46 g, 
0.01 mol) in 1,4-dioxane (40 mL) containing triethyl amine (1.50 mL) elemental sulfur (0.32 g, 
0.01 mol) and malononitrile (0.66 g, 0.01 mol) were added. The whole reaction mixture was 
heated under reflux for 2 h then poured onto ice/water containing few drops of hydrochloric acid 
and the formed solid product was collected by filtration.  
 
2-Amino-5-(5-amino-4-cyanothiophen-3-yl)-6-((3-cyano-4,5,6,7-tetrahydrobenzo-[b]thiophen-
2-yl)amino)-4-phenyl-4H-pyran-3-carbonitrile (9a). Yield: 70%; m.p.: 230-235 oC; IR (KBr, 
cm-1) ν: 3453-3341 (2NH2, NH), 3053 (CH aromatic), 2983, 2851 (CH aliphatic), 2228, 2223-
2220 (3CN), 1636 (C=C); 1H NMR (DMSO-d6) δ: 1.43-2.51 (m, 8H, 4CH2), 4.38, 4.70 (2s, 4H, 
D2O exchangeable, 2NH2), 5.96 (s, 1H, thiophene H-5), 6.04  (s, 1H, pyran H-4), 7.28-7.46 (m, 
5H, C6H5), 8.39 (s, 1H, NH, D2O exchangeable); 
13C NMR (DMSO-d6, 400 MHz): 29.3, 30.5, 
32.9, 38.3 (4CH2), 88.6 (pyran C-4), 115.7, 116.0, 116.3 (3CN), 119.5, 120.8, 121.3, 122.9, 
123.3, 126.9, 127.5, 130.8, 132.6, 133.5, 137.7, 138.5, 139.7, 140.6, 142.9, 145.2 (benzene, 
pyran, two thiophene C); MS (m/z, %): 496 (42). Anal. calcd. for C26H20N6OS2 (496.61): C, 
62.88; H, 4.06; N, 16.92; S, 12.91. Found: C, 62.94; H, 4.33; N, 17.18; S, 13.07. 
 
2-Amino-5-(5-amino-4-cyanothiophen-3-yl)-4-(4-chlorophenyl)-6-((3-cyano-4,5,6,7-tetrahydro- 
benzo[b]thiophen-2-yl)amino)-4H-pyran-3-carbonitrile (9b). Yield 84%; m.p.: 216-218 oC; IR 
(KBr, cm-1) ν: 3481-3342 (2NH2, NH), 3052 (CH aromatic), 2948-2881 (CH aliphatic), 2226, 
2223-2220 (3CN), 1689 (CO), 1632 (C=C); 1H NMR (DMSO-d6) δ: 1.76-2.48 (m, 8H, 4CH2), 
4.36, 4.90 (2s, 4H, D2O exchangeable, 2NH2), 5.95 (s, 1H, thiophene H-5), 6.04 (s, 1H, pyran 
H-4), 7.30-7.48 (m, 4H, C6H4), 8.29  (s, 1H, NH, D2O exchangeable); 
13C NMR (DMSO-d6, 400 
MHz): 28.1, 31.4, 31.9, 35.8 (4CH2), 88.9 (pyran C-4), 116.1, 116.7, 117.3 (3CN), 120.8, 121.9, 
122.4, 123.8, 125.3, 126.9, 128.8, 130.4, 131.3, 132.7, 136.5, 137.9, 138.0, 140.8, 142.8, 143.6 
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(benzene, pyran, two thiophene C); MS (m/z, %): 531 (32). Anal. calcd. for C26H19ClN6OS2 
(531.05): C, 58.80; H, 3.61; N, 15.83; S, 12.08. Found: C, 59.28; H, 3.94; N, 16.33; S, 11.94.  
 
2-Amino-5-(5-amino-4-cyanothiophen-3-yl)-4-(4-chlorophenyl)-6-((3-cyano-4,5,6,7-tetrahydro- 
benzo[b]thiophen-2-yl)amino)-4H-pyran-3-carbonitrile (9c). Yield 73%; m.p.: >300 oC; IR 
(KBr, cm-1) ν: 3472-3321 (2NH2,  NH), 3058 (CH aromatic), 2973, 2890 (CH aliphatic), 2227, 
2222-2220 (3CN), 1688 (CO), 1633 (C=C); 1H NMR (DMSO-d6) δ: 1.68-2.42 (m, 8H, 4CH2), 
3.24 (s, 3H, CH3), 4.42, 4.57  (2s, 4H, D2O exchangeable, 2NH2), 6.08 (s, 1H, pyran H-4), 6.22 
(s, 1H, thiophene H-5), 7.28-7.36 (m, 4H, C6H4), 8.34  (s, 1H, NH, D2O exchangeable); 
13C 
NMR (DMSO-d6, 400 MHz): 28.6, 31.6, 32.9, 35.8 (4CH2), 32.3 (CH3), 88.7 (pyran C-4), 
115.6, 116.5, 116.8 (3CN), 119.8, 121.6, 122.4, 123.9, 124.9, 127.5, 128.5, 130.4, 132.3, 132.9, 
134.3, 135.7, 136.2, 140.9, 141.8, 143.9 (benzene, pyran, twothiophene C); MS (m/z, %): 526 
(26). Anal. calcd. for C27H22N6O2S2  (526.63): C, 61.58; H, 4.21; N, 15.98; S, 12.18. Found: C, 
61.83; H, 4.47; N, 16.31; S, 12.22.  
 
General procedure for the synthesis of the 5-amino-4-cyanothiophen-3-yl)-4-phenyl-4H-
pyridine derivatives 10a-c 
 
To a solution of any of compound 8a (4.15 g, 0.01 mol), 8b (4.49 g, 0.01 mol) or 8c (4.45 g, 
0.01 mol) in 1,4-dioxane (40 mL) containing triethyl amine (1.50 mL) elemental sulfur  (0.32 g, 
0.01 mol) and malononitrile (0.66 g, 0.01 mol) were added. The whole reaction mixture was 
heated under reflux for 2 h then poured onto ice/water containing few drops of hydrochloric acid 
and the formed solid product was collected by filtration.  
 
2-Amino-5-(5-amino-4-cyanothiophen-3-yl)-6-((3-cyano-4,5,6,7-tetrahydrobenzo-[b]thiophen-
2-yl)amino)-4-phenyl-1,4-dihydropyridine-3-carbonitrile (10a). Yield: 83%; m.p. 145 oC; IR 
(KBr, cm-1) ν: 3463-3329 (2NH2, 2NH), 3056 (CH aromatic), 2967-2851 (CH aliphatic), 2227, 
2222-2220 (3CN), 1631 (C=C); 1H NMR (DMSO-d6) δ: 1.48-2.39 (m, 8H, 4CH2), 4.43, 4.72 
(2s, 4H, D2O exchangeable, 2NH2), 5.99 (s, 1H, thiophene H-5), 6.03  (s, 1H, pyridine H-4), 
7.22-7.42 (m, 5H, C6H5), 8.54, 8.65 (2s, 2H, 2NH, D2O exchangeable); 
13C NMR (DMSO-d6, 
400 MHz): 29.0, 30.8, 32.9, 38.9 (4CH2), 88.2 (pyridine C-4), 116.1, 116.3, 116.8 (3CN), 120.6, 
121.0, 121.6, 122.0, 124.7, 127.9, 128.3, 130.5, 133.2, 133.9, 137.7, 138.0, 139.3, 141.3, 144.2, 
146.8 (benzene, pyridine, two thiophene C); MS (m/z, 495 (33). Anal. calcd. for C26H21N7S2 
(495.62): C, 63.01; H, 4.27; N, 19.78; S, 12.94. Found: C, 62.88; H, 4.51; N, 19.49; S, 13.19. 
 
 2-Amino-5-(5-amino-4-cyanothiophen-3-yl)-6-((3-cyano-4,5,6,7-tetrahydrobenzo-[b]thiophen-
2-yl)amino)-4-chlorophenyl-1,4-dihydropyridine-3-carbonitrile (10b). Yield 88%; m.p. 180-182 
oC; IR (KBr, cm-1) ν: 3463-3313 (2NH2, 2NH), 3054 (CH aromatic), 2942-2870 (CH aliphatic), 
2224, 2222-2220 (3CN), 1630 (C=C); 1H NMR (DMSO-d6) δ: 1.73-2.45 (m, 8H, 4CH2), 4.29, 
4.45 (2s, 4H, D2O exchangeable, 2NH2), 5.99 (s, 1H, thiophene H-5), 6.02  (s, 1H, pyridine H-
4), 7.26-7.43 (m, 4H, C6H4), 8.33, 8.65 (2s, 2H, 2NH, D2O exchangeable); 
13C NMR (DMSO-
d6, 400 MHz): 28.3, 31.8, 32.8, 37.1 (4CH2), 88.6 (pyridine C-4), 116.0, 116.4, 116.9 (3CN), 
120.3, 121.6, 121.8, 122.2, 124.8, 127.0, 128.3, 131.9, 132.8, 134.9, 138.3, 138.5, 139.2 141.2, 
142.8, 143.9 (benzene, pyridine, two thiophene C); MS (m/z,  530 (42). Anal. calcd. for 
C26H20ClN7S2 (530.07): C, 58.91; H, 3.80; N, 18.50; S, 12.10. Found: C, 59.09; H, 3.66; N, 
18.83; S, 11.89.  
 
2-Amino-5-(5-amino-4-cyanothiophen-3-yl)-6-((3-cyano-4,5,6,7-tetrahydrobenzo-[b]thiophen-
2-yl)amino)-4-methoxyphenyl-1,4-dihydropyridine-3-carbonitrile (10c). Yield 68%; m.p. 110 
oC; IR (KBr, cm-1) ν: 3488-3342 (2NH2, 2NH), 3054 (CH aromatic), 2960, 2892 (CH aliphatic), 
2225, 2222-2220 (3CN), 1633 (C=C); 1H NMR (DMSO-d6) δ: 1.68-2.42 (m, 8H, 4CH2), 3.26 (s, 
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3H, CH3), 4.46, 4.69  (2s, 4H, D2O exchangeable, 2NH2), 6.04 (s, 1H, pyridine H-4), 6.11 (s, 
1H, thiophene H-5), 7.25-7.39 (m, 4H, C6H5), 8.31, 8.63 (2s, 2H, 2NH, D2O exchangeable); 
13C 
NMR (DMSO-d6, 400 MHz): 29.0, 30.8, 33.4, 36.7 (4CH2), 31.8 (CH3), 88.9 (pyridine C-4), 
115.7, 116.1, 116.3 (3CN), 120.2, 122.3, 122.8, 122.4, 125.3, 127.8, 129.1, 130.9, 132.7, 133.6, 
135.0, 136.2, 138.1, 140.4, 142.5, 143.2 (benzene, pyridine, two thiophene C); MS (m/z, %): 
525 (26). Anal. calcd. for C27H23N7OS2  (525.65): C, 61.69; H, 4.41; N, 18.65; S, 12.20. Found: 
C, 62.33; H, 4.68; N, 18.89; S, 12.41.  
 
General procedure for the synthesis of the thiophene derivatives 12a,b 
 
To a solution of compound 5 (2.62 g, 0.01 mol), in 1,4-dioxane (40 mL) containing triethyl 
amine (1.50 mL) elemental sulfur (0.32 g, 0.01 mol) and either of  malononitrile (0.66 g, 0.01 
mol) or ethyl cyanoacetate (1.07 g, 0.01 mol) were added. The whole reaction mixture was 
heated under reflux for 4 h then poured onto ice/water containing few drops of hydrochloric acid 
and the formed solid product was collected by filtration. 
 
2-(5-Amino-4-cyanothiophen-3-yl)-N-(3-cyano-4,5,6,7-tetrahydrobenzo-[b]thiophen-2-yl)aceta- 
mide (12a). Yield 80%; m.p. 120 oC; IR (KBr, cm-1) ν: 3459-3328 (NH2, NH), 3053 (CH 
aromatic), 2972, 2869 (CH aliphatic), 2224, 2220 (2CN),  1703 (CO), 1630 (C=C); 1H NMR 
(DMSO-d6) δ: 1.65-2.41 (m, 8H, 4CH2), 3.88 (s, 2H, CH2), 4.42  (s, 2H, D2O exchangeable, 
NH2), 6.18 (s, 1H, thiophene H-5), 8.33 (s, 1H, NH, D2O exchangeable); 
13C NMR (DMSO-d6, 
400 MHz): 29.0, 30.5, 33.1, 36.9 (4CH2), 43.8 (CH2), 116.3, 116.6 (2CN), 130.8, 133.1, 133.6, 
137.1, 138.1, 142.9, 143.6 (two thiophene C), 166.2 (CO); MS (m/z, %): 342 (48). Anal. calcd. 
for C16H14N4OS2  (342.44): C, 56.12; H, 4.12; N, 16.36; S, 18.73. Found: C, 56.08; H, 4.33; N, 
16.59; S, 18.92.   
 
Ethyl-2-amino-4-(2-((3-cyano-4,5,6,7-tetrahydrobenzo[b]thiophen-2-yl)amino)-2-oxoethyl)thio- 
phene-3-carboxylate (12b). Yield 67%; m.p. 110 oC; IR (KBr, cm-1) ν: 3483-3330 (NH2, NH), 
3054 (CH aromatic), 2983, 2863 (CH aliphatic), 2220 (CN), 1705, 1688 (2 CO), 1632 (C=C); 
1H NMR (DMSO-d6) δ: 1.16 (t, 3H, J = 6.95 Hz, CH3), 1.62-2.48 (m, 8H, 4CH2), 3.92 (s, 2H, 
CH2), 4.21 (q, 2H, J = 6.95 Hz, CH2), 4.49  (s, 2H, D2O exchangeable, NH2), 6.18 (s, 1H, 
thiophene H-5), 8.33 (s, 1H, NH, D2O exchangeable); 
13C NMR (DMSO-d6, 400 MHz): 14.2 
(ester CH3), 29.2, 30.9, 33.3, 36.9 (4CH2), 43.6 (CH2), 53.8 (ester CH2),  116.4 (CN), 130.2, 
133.3, 133.9, 135.8, 137.4, 142.6, 144.2  (two thiophene C), 166.8, 168.3 (2CO); MS (m/z, %): 
389 (31). Anal. calcd. for C18H19N3O3S2  (389.49): C, 55.51; H, 4.92; N, 10.79; S, 16.47. Found: 
C, 55.39; H, 5.18; N, 11.09; S, 16.62. 
 
3-Oxo-N-(3-(4-oxo-4,5-dihydrothiazol-2-yl)-4,5,6,7-tetrahydrobenzo-[b]thiophen-2-yl)butane- 
mide (14). To a solution of compound 5 (2.62 g, 0.01 mol) in acetic acid (50 mL), thioglycollic 
acid (0.92 g, 0.01 mol) was added. the reaction mixture was heated under reflux for 2 h then was 
left to cool. The solid product produced upon pouring onto ice/water mixture was collected by 
filtration. Yield 58%; m.p. 140 oC; IR (KBr, cm-1) ν: 3495-3321 (NH), 2972, 2829 (CH 
aliphatic), 1708, 1689-1660 (3CO), 1636 (C=C); 1H NMR (DMSO-d6) δ: 2.36 (s, 3H, CH3), 
1.59-2.45 (m, 8H, 4CH2), 3.96 (s, 2H, CH2), 5.30 (s, 2H, thiazole CH2), 8.33 (s, 1H, NH, D2O 
exchangeable); 13C NMR (DMSO-d6, 400 MHz): 29.6, 29.6, 32.8, 34.9 (4CH2), 45.2 (CH2), 89.2 
(thiazole CH2), 132.6, 136.2, 142.9, 144.9 (thiophene C), 164.8, 163.6, 169.0 (3CO), 170.3 
(C=N); MS (m/z, %): 336 (24). Anal. calcd. for C15H16N2O3S2  (336.43): C, 53.55; H, 4.79; N, 
8.33; S, 19.06. Found: C, 53.80; H, 4.88; N, 8.58; S, 18.79. 
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The newly synthesized thiophene derivatives were obtained in optimal yields and their 
structures were confirmed using the analytical and spectral tools. The antitumor evaluations of 
the synthesized compounds against the three cancer cell lines MCF-7, NCI-H460 and SF-268 
showed that compounds 9a, 9c, 12a and 14 have the highest potencies against the three cancer 
cell lines among the tested compounds.  
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